Haemonetics Sets Date For Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025

(MENAFN- PR Newswire)

BOSTON, Jan. 8, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE ) announced that the Company intends to publish third quarter fiscal year 2025 financial results at 6:00 am ET on Thursday, February 6, 2025. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on February 6, 2025.

The call can be accessed via teleconference at: Q3 2025 Haemonetics Corporation earnings Conference Call.
Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link:

A replay of the conference call and webcast will be available for one year beginning on February 6, 2025 at 11:00 am ET using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS

Haemonetics
(NYSE: HAE ) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit
.

Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury		David Trenk, Manager-Investor Relations
(781) 356-9763		(203) 733-4987
[email protected]		[email protected]
Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
[email protected]

SOURCE Haemonetics Corporation

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN08012025003732001241ID1109070039